Cleared Traditional

K131817 - EXTRACORPOREAL SHOCK WAVE LITHOTRIPTER

K131817 is an FDA 510(k) clearance for EXTRACORPOREAL SHOCK WAVE LITHOTRIPTER, manufactured by Osmunda Medical Device Consulting Co., Ltd.. The device is a Class 2 Gastroenterology & Urology device with product code LNS cleared through the Traditional 510(k) pathway after a 463-day FDA review.

K131817 · Osmunda Medical Device Consulting Co., Ltd. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2014
Decision
463d
Days
Class 2
Risk

K131817 is an FDA 510(k) clearance for the EXTRACORPOREAL SHOCK WAVE LITHOTRIPTER. Classified as Lithotriptor, Extracorporeal Shock-wave, Urological (product code LNS), Class II - Special Controls.

Submitted by Osmunda Medical Device Consulting Co., Ltd. (Guangzhou, Guangdong, CN). The FDA issued a Cleared decision on September 26, 2014 after a review of 463 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5990 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Gastroenterology & Urology submissions.

View all Osmunda Medical Device Consulting Co., Ltd. devices

FDA 510(k) Submission Details - K131817

510(k) Number K131817 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 20, 2013
Decision Date September 26, 2014
Days to Decision 463 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
333d slower than avg
Panel avg: 130d · This submission: 463d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LNS Device Classification - Class 2, Special Controls

Product Code LNS Lithotriptor, Extracorporeal Shock-wave, Urological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5990
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - LNS Lithotriptor, Extracorporeal Shock-wave, Urological

All 18
Devices cleared under the same product code (LNS) and FDA review panel - the closest regulatory comparables to K131817.
Modulith SLX-F2
K201001 · Karl Storz Endoscopy America · Mar 2021
Delta III Lithotripter
K201074 · Dornier Medtech America, Inc. · Sep 2020
Delta III Lithotripter
K172084 · Dornier Medtech America, Inc. · Aug 2017
GEMINI LITHOTRIPTER
K121656 · Dornier Medtech America, Inc. · Sep 2012
MODULTH SLK
K120769 · KARL STORZ Endoscopy-America, Inc. · Jun 2012
LITHOSKOP
K070665 · Siemens Medical Solutions USA, Inc. · Jan 2008